I disagree. Lots of work has been completed after the previous trial to get us where we are now. That being in investigation of the biomarkers and other indications etc. The company is well placed with a potential of a platform drug.
We are still some way away from paydirt milestones. Until we arrive there the share price will drift. The good news is, upticks are being better supported volume wise than pullbacks. So this would suggest the price should run hard when the time arrives.
- Forums
- ASX - By Stock
- PER - Megathread
I disagree. Lots of work has been completed after the previous...
-
- There are more pages in this discussion • 94 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PER (ASX) to my watchlist
|
|||||
Last
8.5¢ |
Change
0.001(1.19%) |
Mkt cap ! $76.63M |
Open | High | Low | Value | Volume |
8.3¢ | 8.5¢ | 8.3¢ | $32.58K | 385.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 3647 | 8.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.5¢ | 8842 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 3647 | 0.084 |
1 | 3577 | 0.083 |
1 | 5500 | 0.082 |
2 | 66300 | 0.080 |
2 | 212658 | 0.078 |
Price($) | Vol. | No. |
---|---|---|
0.085 | 8842 | 1 |
0.086 | 6500 | 1 |
0.087 | 125000 | 1 |
0.089 | 135000 | 2 |
0.090 | 286175 | 3 |
Last trade - 16.10pm 04/07/2024 (20 minute delay) ? |
Featured News
PER (ASX) Chart |